SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001346302-20-000075
Filing Date
2020-12-10
Accepted
2020-12-10 16:52:44
Documents
1
Period of Report
2020-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160763715074716.html 4  
1 FORM 4 wf-form4_160763715074716.xml 4 4759
  Complete submission text file 0001346302-20-000075.txt   6172
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEWLINK GENETICS CORP. 2503 SOUTH LOOP DR., SUITE 5100 AMES IA 50010
Business Address
Edick Paul R (Reporting) CIK: 0001531178 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38536 | Film No.: 201381205